![]() Necessary cookies are absolutely essential for the website to function properly. San Francisco, CA: Portola Pharmaceuticals, Inc May 2018. ![]() Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. Continued approval for this indication may be contingent upon the results of studies to demonstrate an improvement in hemostasis in patients.Ĭonnolly SJ, Milling, Jr, TJ., Eikelboom, et al. To reduce thromboembolic risk, resume anticoagulant therapy as soon as medically appropriate following treatment with AndexXa ®.įDA gave this drug an accelerated approval and is the only approved product for reversal of apixaban and rivaroxaban. Also, monitor for symptoms and signs that precede cardiac arrest and provide treatment as needed. The package insert recommends to monitor for thromboembolic events and initiate anticoagulation when medically appropriate.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |